日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reduced Exercise Capacity in Breast Cancer Compared to HFpEF: Mechanistic Insights From Invasive Exercise Testing

与HFpEF患者相比,乳腺癌患者的运动能力下降:来自侵入性运动试验的机制性见解

Landsteiner, Isabela; Foulkes, Stephen J; Campain, Joseph; Camphausen, Carly E; Zlotoff, Daniel A; Lewis, Gregory D; Haykowsky, Mark J

From manual clinical criteria to machine learning algorithms: Comparing outcome endpoints derived from diverse electronic health record data modalities

从人工临床标准到机器学习算法:比较从不同电子健康记录数据模式中获得的结果终点

Chappidi, Shreya; Belue, Mason J; Harmon, Stephanie A; Jagasia, Sarisha; Zhuge, Ying; Tasci, Erdal; Turkbey, Baris; Singh, Jatinder; Camphausen, Kevin; Krauze, Andra V

Spatiotemporal Exciton Tracking with a SPAD Camera

利用SPAD相机进行时空激子追踪

Dall'Aglio, Diana; Brinatti Vazquez, Guillermo D; Bolzonello, Luca; Cusini, Iris; Camphausen, Robin; van Hulst, Niek F

Mesenchymal Stem Cell Treatment of Cutaneous Radiation Injury

间充质干细胞治疗皮肤放射损伤

Sproull, Mary T; Jackson, Luke R; Citrin, Deborah E; Camphausen, Kevin

Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 Study

局部消融治疗后序贯奥希替尼再治疗寡转移进展型 EGFR 突变型非小细胞肺癌:一项 II 期研究

Ghafoor, Azam; Roper, Nitin; Kim, Chul; Hoang, Chuong D; Kesarwala, Aparna H; Camphausen, Kevin A; Farouq, Kamran; Akoth, Elizabeth; Keen, Corrine; Szabo, Eva; Bhageri, Hadi; Rajan, Arun; Guha, Udayan

Serum p-Cresol and 7-HOCA Levels and Fatty Acid and Purine Metabolism Are Associated with Survival, Progression, and Molecular Classification in GB-Serum Proteome and Metabolome Analysis Pre vs. Post Up-Front Chemoirradiation

血清对甲酚和7-HOCA水平以及脂肪酸和嘌呤代谢与GB患者的生存、进展和分子分型相关——一线放化疗前后血清蛋白质组和代谢组分析

Krauze, Andra V; Li, M; Zhao, Y; Tasci, E; Chappidi, S; Cooley Zgela, T; Sproull, M; Mackey, M; Camphausen, K

Partial-body Models of Radiation Exposure

辐射暴露的局部身体模型

Sproull, M; Camphausen, K

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

纳维托克和曲美替尼联合抑制BCL-xL和MEK治疗KRAS或NRAS突变晚期实体瘤的I/II期研究

Corcoran, Ryan B; Do, Khanh T; Kim, Jeong E; Cleary, James M; Parikh, Aparna R; Yeku, Oladapo O; Xiong, Niya; Weekes, Colin D; Veneris, Jennifer; Ahronian, Leanne G; Mauri, Gianluca; Tian, Jun; Norden, Bryanna L; Michel, Alexa G; Van Seventer, Emily E; Siravegna, Giulia; Camphausen, Kyle; Chi, Gary; Fetter, Isobel J; Brugge, Joan S; Chen, Helen; Takebe, Naoko; Penson, Richard T; Juric, Dejan; Flaherty, Keith T; Sullivan, Ryan J; Clark, Jeffrey W; Heist, Rebecca S; Matulonis, Ursula A; Liu, Joyce F; Shapiro, Geoffrey I

MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma

MGMT 抑制可调节 GBM、GSC 和黑色素瘤的放射反应

Hong Shik Yun, Tamalee R Kramp, Kamalakannan Palanichamy, Philip J Tofilon, Kevin Camphausen

Understanding the Immune System and Biospecimen-Based Response in Glioblastoma: A Practical Guide to Utilizing Signal Redundancy for Biomarker and Immune Signature Discovery

了解胶质母细胞瘤的免疫系统和基于生物样本的反应:利用信号冗余进行生物标志物和免疫特征发现的实用指南

Jackson, Luke R; Erickson, Anna; Camphausen, Kevin; Krauze, Andra V